Cancer screening in the United States, 2012

Each year the American Cancer Society (ACS) publishes a summary of its recommendations for early cancer detection, a report on data and trends in cancer screening rates, and select issues related to cancer screening. In this issue of the journal, current ACS cancer screening guidelines are summarized, as are the latest data on the use of cancer screening from the National Health Interview Survey. CA Cancer J Clin 2012. © 2012 American Cancer Society.

[1]  V. Moyer,et al.  Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2012, Annals of Internal Medicine.

[2]  L. Tanoue,et al.  Reduced lung cancer mortality with low-dose computed tomographic screening , 2011 .

[3]  L. Tanoue.  Cancer Statistics, 2011: The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths , 2012 .

[4]  D. Ransohoff,et al.  New American Cancer Society process for creating trustworthy cancer screening guidelines. , 2011, JAMA.

[5]  S. Duffy,et al.  Mammographic screening and "overdiagnosis". , 2011, Radiology.

[6]  L. Tabár,et al.  Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. , 2011, Radiology.

[7]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[8]  J. Gohagan,et al.  Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial. , 2011, JAMA.

[9]  Karen Davis,et al.  How the Affordable Care Act Will Strengthen the Nation's Primary Care Foundation , 2011, Journal of General Internal Medicine.

[10]  Laura A. Levit,et al.  COMMITTEE ON STANDARDS FOR SYSTEMATIC REVIEWS OF COMPARATIVE EFFECTIVENESS RESEARCH , 2011 .

[11]  S. Greenfield,et al.  COMMITTEE ON STANDARDS FOR DEVELOPING TRUSTWORTHY CLINICAL PRACTICE GUIDELINES , 2011 .

[12]  D. Buckman,et al.  Are Physicians’ Recommendations For Colorectal Cancer Screening Guideline-Consistent? , 2011, Journal of General Internal Medicine.

[13]  P. Marcus,et al.  U.S. primary care physicians' lung cancer screening beliefs and recommendations. , 2010, American journal of preventive medicine.

[14]  Yi Li,et al.  Tumor markers for early detection of ovarian cancer , 2010, Expert review of molecular diagnostics.

[15]  S. Taplin,et al.  Organizational factors and the cancer screening process. , 2010, Journal of the National Cancer Institute. Monographs.

[16]  Jasmin A. Tiro,et al.  Too Much of a Good Thing? Physician Practices and Patient Willingness for Less Frequent Pap Test Screening Intervals , 2010, Medical care.

[17]  Stephen W Duffy,et al.  Absolute numbers of lives saved and overdiagnosis in breast cancer screening, from a randomized trial and from the Breast Screening Programme in England , 2010, Journal of medical screening.

[18]  Benjamin F. Crabtree,et al.  Principles of the Patient-Centered Medical Home and Preventive Services Delivery , 2010, The Annals of Family Medicine.

[19]  A. D'Amico,et al.  American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010 , 2010, CA: a cancer journal for clinicians.

[20]  D. Saslow,et al.  Cancer Screening in the United States, 2010: A Review of Current American Cancer Society Guidelines and Issues in Cancer Screening , 2010, CA: a cancer journal for clinicians.

[21]  Philadelphia County,et al.  National, State, and Local Area Vaccination Coverage among Adolescents Aged 13-17 Years — United States, 2009 , 2010 .

[22]  Peter H Gann,et al.  Prostate specific antigen best practice statement: 2009 update. , 2009, The Journal of urology.

[23]  Brian J Zikmund-Fisher,et al.  Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study). , 2009, Archives of internal medicine.

[24]  Sally W Vernon,et al.  Colorectal cancer screening by primary care physicians: recommendations and practices, 2006-2007. , 2009, American journal of preventive medicine.

[25]  Matthew Burnell,et al.  Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) , 2009, Journal of Family Planning and Reproductive Health Care.

[26]  S. Stokley,et al.  National, state, and local area vaccination coverage among adolescents aged 13-17 years--United States, 2008. , 2009, MMWR. Morbidity and mortality weekly report.

[27]  Amy B. Knudsen,et al.  Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.

[28]  S. Buys,et al.  The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial. , 2008, Gynecologic oncology.

[29]  P. Maisonneuve,et al.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps. , 2008, Gastroenterology.

[30]  Perry J Pickhardt,et al.  Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi‐Society Task Force on Colorectal Cancer, and the American College of Radiology * † , 2008, CA: a cancer journal for clinicians.

[31]  O. Brawley,et al.  Cancer Screening in the United States, 2008: A Review of Current American Cancer Society Guidelines and Cancer Screening Issues , 2008, CA: a cancer journal for clinicians.

[32]  Vaccination coverage among adolescents aged 13-17 years - United States, 2007. , 2008, MMWR. Morbidity and mortality weekly report.

[33]  H. Beydoun,et al.  Predictors of colorectal cancer screening behaviors among average-risk older adults in the United States , 2008, Cancer Causes & Control.

[34]  A. Moyer,et al.  Tailored interventions to promote mammography screening: a meta-analytic review. , 2007, Preventive medicine.

[35]  J. Elmore,et al.  Delivery of cancer screening: how important is the preventive health examination? , 2007, Archives of internal medicine.

[36]  M. Yaffe,et al.  American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007, CA: a cancer journal for clinicians.

[37]  J. T. Cox,et al.  American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors , 2007, CA: a cancer journal for clinicians.

[38]  Michael J Goodman,et al.  Priorities among effective clinical preventive services: results of a systematic review and analysis. , 2006, American journal of preventive medicine.

[39]  Charles J. Kahi,et al.  Guidelines for Colonoscopy Surveillance after Cancer Resection: A Consensus Update by the American Cancer Society and US Multi‐Society Task Force on Colorectal Cancer * † , 2006, CA: a cancer journal for clinicians.

[40]  Robert H Fletcher,et al.  Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. , 2006, CA: a cancer journal for clinicians.

[41]  Sw Veterans.  Accuracy of Screening for Fecal Occult Blood on a Single Stool Sample Obtained by Digital Rectal Examination: A Comparison With Recommended Sampling Practice , 2005 .

[42]  David A. Fishman,et al.  The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer. , 2005, American journal of obstetrics and gynecology.

[43]  T. Reynolds,et al.  The role of CA125 in clinical practice , 2005, Journal of Clinical Pathology.

[44]  D. Lieberman,et al.  Accuracy of Screening for Fecal Occult Blood on a Single Stool Sample Obtained by Digital Rectal Examination: A Comparison with Recommended Sampling Practice , 2005, Annals of Internal Medicine.

[45]  Patrick Neven,et al.  Endometrial cancer. , 2005, Lancet.

[46]  M. Duffy,et al.  CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use , 2004, International Journal of Gynecologic Cancer.

[47]  D. Easton,et al.  The BOADICEA model of genetic susceptibility to breast and ovarian cancer , 2004, British Journal of Cancer.

[48]  U. P. S. T. Force.  Lung Cancer Screening: Recommendation Statement , 2004, Annals of Internal Medicine.

[49]  Stephen W Duffy,et al.  A breast cancer prediction model incorporating familial and personal risk factors , 2004, Hereditary Cancer in Clinical Practice.

[50]  A. Ellis.  Breast , 2002, BMJ : British Medical Journal.

[51]  L. Tabár,et al.  Quantifying the potential problem of overdiagnosis of ductal carcinoma in situ in breast cancer screening. , 2003, European journal of cancer.

[52]  M. Cowen,et al.  The impact of a celebrity promotional campaign on the use of colon cancer screening: the Katie Couric effect. , 2003, Archives of internal medicine.

[53]  S. Vernon,et al.  Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message? , 2003, American journal of public health.

[54]  W. P. Evans,et al.  American Cancer Society Guidelines for Breast Cancer Screening: Update 2003 , 2003, CA: a cancer journal for clinicians.

[55]  Diane Solomon,et al.  American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer , 2003, Journal of lower genital tract disease.

[56]  S. Woolf,et al.  Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. , 2003, Gastroenterology.

[57]  B. Levin,et al.  Emerging Technologies in Screening for Colorectal Cancer: CT Colonography, Immunochemical Fecal Occult Blood Tests, and Stool Screening Using Molecular Markers , 2003, CA: a cancer journal for clinicians.

[58]  A. Moscicki,et al.  American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer , 2002, CA: a cancer journal for clinicians.

[59]  Giovanni Parmigiani,et al.  BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[60]  L. Walter,et al.  Cancer screening in elderly patients: a framework for individualized decision making. , 2001, JAMA.

[61]  R Wender,et al.  American Cancer Society Guidelines for the Early Detection of Cancer: Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers: ALSO: Update 2001—Testing for Early Lung Cancer Detection , 2001, CA: a cancer journal for clinicians.

[62]  John K. Gohagan,et al.  The prostate, lung, colorectal and ovarian (PLCO) cancer screening trial , 2000 .

[63]  P C Prorok,et al.  Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. , 2000, Controlled clinical trials.

[64]  G. Strauss,et al.  Varese meeting report. , 1999, Lung cancer.

[65]  David R. Holtgrave,et al.  USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus: A Summary , 1996, Annals of Internal Medicine.

[66]  N Risch,et al.  Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction , 1994, Cancer.

[67]  1989 survey of physicians' attitudes and practices in early cancerdetection , 1990, CA: a cancer journal for clinicians.

[68]  M. Gail,et al.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.

[69]  Survey of physicians‚ attitudes and practices in early cancer detection , 1985, CA: a cancer journal for clinicians.

[70]  D. Eddy.  ACS report on the cancer-related health checkup. , 1980, CA: a cancer journal for clinicians.

[71]  C. Fox,et al.  Breast-cancer screening. , 1979, Lancet.

[72]  Ja Wilson,et al.  Principles and practice of screening for disease , 1968 .

[73]  Rascon.  [The National Cancer Institute]. , 1953, Boletin cultural e informativo - Consejo General de Colegios Medicos de Espana.